Ascenta Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
Ascenta Therapeutics Inc. thinks it has the right technology and team to make cancer a manageable disease. Its orally bioavailable small molecules are designed to hit key proteins mis-expressed in tumor cells-some of which are the targets of current biologics.